FARN.L Gross Margin

The Gross Margin of Faron Pharmaceuticals Oy (FARN.L) is 95.19%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

FARN.L Gross Margin - Historical Value

Date	Value
2024-12-31	95.19%
2023-12-31	95.19%

FARN.L Gross Margin - Peers Comparison

Ticker	Name	Value
ADOC.PA	Adocia SA	87.98%
BONEH.HE	BBS-Bioactive Bone Substitutes Oyj	7775.20%
ETX.L	E-Therapeutics PLC	100.00%
GNRO.PA	Geneuro SA	7775.20%
SCLP.L	Scancell Holdings PLC	90.13%
XBRANE.ST	Xbrane Biopharma AB	90.83%
MDG1.DE	Medigene AG	72.77%
RENE.L	ReNeuron Group PLC	100.00%
XSPRAY.ST	XSpray Pharma AB (publ)	2539.90%
ALHYG.PA	Hybrigenics SA	99.47%
HPHA.DE	Heidelberg Pharma AG	74.01%
MAB.WA	Mabion SA	75.54%
ORY.MC	Oryzon Genomics SA	-4700.00%
PCIB.OL	PCI Biotech Holding ASA	100.00%
TILS.L	Tiziana Life Sciences PLC	63.16%
TRVX.OL	Targovax ASA	7775.20%
VSC.DE	4Sc AG	97.20%
ALQGC.PA	Quantum Genomics SA	-14205.07%
BLR.WA	Blirt SA	77.13%
OXUR.BR	Oxurion NV	-1333.33%
ALSEN.PA	Sensorion SA	7775.20%
BINV.ST	BioInvent International AB	42.37%
DMYD B.ST	Diamyd Medical AB	-10161.54%
EGTX.ST	Egetis Therapeutics AB (publ)	74.84%
NANOV.OL	Nordic Nanovector ASA	7775.20%
SANION.ST	Saniona AB	85.03%
KURN.SW	Kuros Biosciences AG	109.30%
MDXH.BR	MDxHealth SA	51.74%